艰难梭菌荚膜的研究

本文采用提取细菌荚膜多糖的三种方法,提取艰难梭菌(Clostridium difficile)的荚膜多糖,经鉴定证实,该菌荚膜是由多糖和蛋白质两种成份组成。这不仅证明该菌存在荚膜,而且为进一步研究该菌的生物学特性提供了有利条件。     

粪菌移植研究的文献计量学和可视化分析

【背景】粪菌移植是近年医学领域研究的热点,不但能够治疗消化系统疾病,而且在神经及精神系统、心血管系统相关疾病的治疗中均有不错的疗效,有着广阔的应用前景。【目的】掌握国内外粪菌移植的研究现状、热点及发展趋势,为相关领域科研工作者的研究提供参考。【方法】基于Web of Science核心数据库,通过CiteSpace对2011-2021年的年度发文量、作者、国家、期刊、被引情况和关键词等进行可视化分析。【结果】筛选后共纳入4 905篇文献,目前全球粪菌移植研究的文献数量呈快速增长趋势;美国和中国是发文量最多的国家。中国学者的总发文量虽然位居世界第二,但中心度和篇均被引频次较低,说明受关注程度及学术影响力不足,在发文质量上还有待提高;Gastroenterology是国内外学者发文量最多的期刊,Frontiers in Microbiology是中国学者发文量最多的期刊;粪菌移植呈现出多学科交叉的发展特点;粪菌移植目前的研究热点主要与肠内疾病(炎症性肠病、艰难梭菌感染)和肠外疾病(如抑郁、冠状动脉粥样硬化等)有关;粪菌移植在未成年人中的应用、对胰岛素敏感度的影响、测序技术在肠道菌群的应用及...     

梭菌属分类研究进展:现状和展望

目前构成梭菌属的微生物在系统发育和表型特征上不一致。多相分类数据表明,梭菌属物种之间差异大。大量基于16S rRNA 基因的系统发育研究表明,梭菌属应被限定为梭菌属类群I,作为狭义梭菌属(Clostridium sensu stricto)。尽管有这方面认识,梭菌属新物种仍持续增加,这些新物种并不能与梭菌属类群I 和标准种丁酸梭菌(C. butryicum)形成一致分支,引发梭菌属分类上的混乱。本文明确了梭菌属物种的范围,即只包括模式种和梭菌属类群I。此外,4 个物种念珠状真杆菌(Eubacterium moniliforme)、旋舞真杆菌(Eubacterium tarantellae)、最大八叠球菌(Sarcina maxima)和胃八叠球菌(Sarcina ventriculi)应被调至梭菌属,分别命名为念珠状梭菌(Clostridium moniliforme)、旋舞梭菌(Clostridium tarantellae)、最大梭菌(Clostridium maximum)和胃梭菌(Clostridium ventriculi)。一个新属哈撒韦氏菌属(Hathewaya)被提议成立,3 个梭菌属物种溶组织梭菌(Clostridium histolyticum)、泥渣梭菌(Clostridium limosum)和解朊梭菌(Clostridiumproteolyticum)重新归为溶组织哈撒韦氏菌(Hathewaya histolytica)、泥渣哈撒韦氏菌(Hathewaya limosa)和解朊哈撒韦氏菌(Hathewaya proteolytica),其中Hathewaya histolytica 为模式种。     

粪菌移植治疗肠易激综合征研究进展

粪菌移植(faecal microbiota transplantation,FMT)是将从健康供体获得的粪便悬液转移至患者消化道,从而恢复肠道正常微生物组成和功能的一种治疗方法。近年来,FMT治疗肠易激综合征(irritable bowel syndrome,IBS)的疗效和经济效益越来越受到研究者的重视。这种方法已经成为艰难梭菌感染(Clostridium difficile infection,CDI)的成熟替代疗法。此外,FMT还在炎症性肠病(inflammatory bowel disease,IBD)和胃肠疾病以外的疾病,如心血管疾病、自身免疫性疾病和代谢综合征等多种疾病的治疗中取得了显著进展。关于FMT仍有许多未解的问题,需要在这一领域进行更多研究。本文就IBS的发病机制、FMT的疗效和安全性进行综述。     

粪菌移植和益生菌在复发性艰难梭菌感染和炎症性肠病中的应用进展

聚集在人体肠道的菌群对维持机体正常的生理功能具有重要作用,肠道菌群的失调会导致复发性艰难梭菌感染及炎症性肠病等疾病。粪菌移植是将健康供者肠道内的功能菌群转移到患病个体的肠道内,重建患者的肠道微生态环境,从而达到治疗的目的。研究发现,粪菌移植在治疗复发性艰难梭菌感染方面表现出较高的治愈率,同时对炎症性肠病有积极的疗效。益生菌是一类能发挥健康作用的活性微生物,当机体摄入足够数量的益生菌,益生菌能在宿主肠道内定植,可以恢复并维持宿主肠道菌群的平衡。益生菌可作为预防复发性艰难梭菌感染的辅助治疗,同时在缓解炎症性肠病方面也有较好的效果。     

粪肠球菌MG 2108对小鼠结肠炎症的缓解作用及机制研究

【目的】为了筛选能抑制鼠类柠檬酸杆菌(Citrobacter rodentium)诱发的小鼠结肠炎的益生菌,并研究其干预机制。【方法】对4株筛选的菌株进行人工模拟胃肠液耐受试验,并体外测试它们对鼠类柠檬酸杆菌的抑制能力,最终筛选出粪肠球菌(Enterococcus faecalis)MG 2108。72只雄性7周龄ICR小鼠经过适应性饲养7d后,被随机分为2组：正常对照组(MC组,24只,生理盐水)和炎症对照组(IC组,48只,1×10¹⁰CFU/mL灌胃鼠类柠檬酸杆菌),7d后各采12只小鼠,通过结肠组织HE染色和炎症因子检测实验,判断炎症模型建成。原MC组(剩下12只小鼠)更名为NC组,用以区别建模前后的正常对照组,IC组随机分成3组：自然恢复组(IR组,12只,生理盐水)、环丙沙星组(CF组,12只,4mg/mL环丙沙星)和粪肠球菌MG 2108组(EF组,12只,1×10⁸CFU/mL粪肠球菌MG 2108)。18d后结束灌胃,所有小鼠麻醉后眼球取血,解剖。【结果】粪肠球菌MG 2108可以缓解和修复鼠类柠檬酸杆菌引发的小鼠结肠和肝脏损伤,并且通过降低炎症细胞因子的表达水平和增加紧密连接蛋白的表达水平,促进了结肠炎症组织的修复。它改变了肠道微生物菌群结构,EF组的肠杆菌属(Enterorhabdus)和阿克曼菌属(Akkermansia)等有益菌群的丰度增加,同时短链脂肪酸也显著增加(P<0.05),并且优于CF组和IR组。【结论】粪肠球菌MG2108是一株有利于肠道健康的益生菌,治疗鼠类柠檬酸杆菌诱导的小鼠结肠炎效果优于环丙沙星,自然恢复组效果明显差于EF组。     

粪菌移植的临床应用研究进展

人类的肠道菌群种类及数量众多,目前被认为是人体的一个特殊器官。肠道菌群在维持肠道的正常生理功能和机体免疫功能方面发挥了重要作用,肠道微生态失衡与炎症性肠病、代谢综合征、肝病、心血管疾病、精神疾病、关节炎等多种肠内外疾病密切相关,纠正肠道微生态失衡将有助于上述疾病的治疗。粪菌移植(fecal microbiota transplantation,FMT)是指将健康人粪便中的功能菌群移植到患者胃肠道内,重建具有正常功能的肠道菌群,以达到治疗肠道和肠道外疾病的目的。目前报道FMT已应用于艰难梭菌感染、炎症性肠病、肠易激综合征、代谢综合征等多种疾病的治疗中。本文就FMT的临床应用现状作一综述。     

肠道菌群与溃疡性结肠炎相关性研究的文献计量及可视化分析

【背景】肠道菌群是溃疡性结肠炎发病的重要影响因素,一直是研究者关注的焦点。【目的】全面分析近20年肠道菌群与溃疡性结肠炎相关性研究的前沿热点和发展趋势,为今后研究提供参考。【方法】从WoSCC检索2000-2020年的文献,并使用VOSviewer 1.6.17、CiteSpace 5.8.R1和在线文献计量分析平台进行分析。【结果】共获得3 146篇出版物。每年的出版物数量和被引用的频率均呈上升趋势。美国在出版物产出、H指数和国际合作方面显示出一定的优势。最有影响力的研究机构和学者分别是美国的哈佛大学和Xavier RJ。期刊共被引分析显示,胃肠道领域的高分专业期刊Gastroenterology位居第一。关键词共现中的“expression”“probiotics”及“Escherichia coli”成为研究的热点。关键词突发检测发现“dysbiosis”“microbiome”和“fecal microbiota transplantation”是最新的研究前沿。【结论】本研究从最新的文献计量学角度分析了肠道菌群与溃疡性结肠炎关系的研究现状和发展趋势,其结果可能有助于研究人员选择合适的期刊和合作者,促进对该领域研究热点和前沿进行更深入的探索。     

丝状真菌Podospora anserina中光敏色素基因的鉴定及功能分析

光敏色素在细菌和植物发育中起着关键作用,但它们在真菌中的生物学功能尚不完全清楚。【目的】探究光敏色素基因PaPhy1和PaPhy2在Podospora anserina有性生殖和无性发育中的作用及其调控机制。【方法】利用同源重组方法对P.anserina中2个光敏色素基因PaPhy1和PaPhy2进行定点敲除,获得光敏色素基因缺失菌株ΔPaPhy1和ΔPaPhy2,并通过遗传杂交构建双重突变体ΔPaPhy1ΔPaPhy2;分析突变型菌株和野生型菌株在不同光照下有性生殖、无性发育、生长速率和活性氧代谢等方面的差异,明确光敏色素基因在P.anserina中的主要功能。【结果】白光和蓝光诱导P.anserina子实体的形成,ΔPaPhy在光照下产生子实体的数量减少,ΔPaPhy的生命周期延长。【结论】光敏色素基因与P.anserina有性生殖密切相关;ΔPaPhy的衰老延迟和活性氧代谢有关。本研究的结果为进一步探索光照对丝状真菌繁殖调控机制以及抗衰老研究提供了新的思路。     

ycjX和ycjF基因在布鲁氏菌热应激中的作用

【背景】细菌应对环境压力的能力对其存活和增殖及引起感染具有重要意义。充分揭示布鲁氏菌应激机制,可为防控布鲁氏菌病提供理论依据。研究发现,ycjX基因在细菌热应激时高表达且可能受σ³²调节,ycjF基因在细菌败血症期间表达显著上升,二者在革兰阴性菌中可能构成操纵子。【目的】研究ycjX和ycjF基因在布鲁氏菌热应激中的作用。【方法】对布鲁氏菌(Brucella)及其ycjX和ycjF双基因缺失株(△ycjXF)和回补株(C△ycjXF)进行热应激试验,计算3株菌的存活率。利用RT-PCR和β-半乳糖苷酶活性检测试验鉴定ycjX和ycjF的操纵子模式和启动子区域活性。利用ChIP试验分析σ³²与ycjX和ycjF的靶向调节关系。表达并纯化pGEX-4T-1-σ³²重组蛋白,凝胶电泳迁移试验分析σ³²与ycjX和ycjF之间的结合关系。【结果】热刺激后△ycjXF存活显著低于Brucella suis S2和C△ycjXF。明确布鲁氏菌ycjX和ycjF为同一转录本,确定其启动子区域具有活性。ChIP试验表明,σ³²可靶向富集在ycjXF启动子区,凝胶电泳迁移试验确定σ³²可与ycjXF体外直接结合。【结论】在σ³²的调节下,ycjX和ycjF在布鲁氏菌热应激中发挥正向作用。     

放线菌代谢产物的研究进展：基于Web of Science (WOS)和中国知网(CNKI)

【背景】放线菌是一类极其重要的微生物,代谢产物丰富,在医药、生物技术、农业和酶工业等领域均有广泛应用。【目的】客观分析放线菌代谢产物的研究进展,为该领域相关工作人员提供有效情报,推动该领域高质量发展。【方法】对Web of Science (WOS)和中国知网(China National Knowledge Infrastructure, CNKI)数据库中放线菌代谢产物的发文数量、发文国家、发文机构、发文期刊、发文出版社、发文作者、被引文章和研究方向进行统计分析,利用H指数对相关影响力进行综合评价,其研究热点、发展趋势通过Cite Space和VOSviewer软件进行可视化分析。【结果】WOS结果显示,放线菌代谢产物研究领域全球影响力最大的国家是美国,影响力最大的机构是美国加利福利亚大学,影响力最大的期刊是美国Applied and Environmental Microbiology,影响力最大的出版社是Elsevier,影响力最大的作者是来自英国约翰英纳斯研究中心微生物学部的Mervyn J Bibb教授。全球放线菌代谢产物领域的主要研究方向是微生物学,研究热点是生物合成。研...     

Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics

Clostridium difficile infection (CDI) is a challenging threat to human health. Infections occur after disruption of the normal microbiota, most commonly through the use of antibiotics. Current treatment for CDI largely relies on the broad‐spectrum antibiotics vancomycin and metronidazole that further disrupt the microbiota resulting in frequent recurrence, highlighting the need for C. difficile‐specific antimicrobials. The cell surface of C. difficile represents a promising target for the development of new drugs. C. difficile possesses a highly deacetylated peptidoglycan cell wall containing unique secondary cell wall polymers. Bound to the cell wall is an essential S‐layer, formed of SlpA and decorated with an additional 28 related proteins. In addition to the S‐layer, many other cell surface proteins have been identified, including several with roles in host colonization. This review aims to summarize our current understanding of these different C. difficile cell surface components and their viability as therapeutic targets.     

基于近10年红球菌发展的文献计量分析

【背景】近些年,越来越多的研究集中在红球菌上,很少有研究人员对现有文献进行全面回顾。【目的】为了探究国内外红球菌领域的研究热点、前沿和未来发展趋势,以便为后续研究人员提供全面直观的参考。【方法】对近10年发表在Web of Science的红球菌领域论文进行统计分析和文献计量分析。通过VOSviewer文献可视化软件绘制作者标签视图和关键词共现网络图。【结果】全球有关红球菌领域的发文量总体呈逐年上升趋势,发表期刊多为微生物学领域的专科期刊,中国和美国的文章发表数和引用数远超其他国家,红球菌的研究内容也主要集中在生物催化、生物降解和非核糖体肽合成酶等方面。【结论】红球菌在世界范围内越来越受到重视,并逐渐成为研究热点,国家和研究机构应继续加强合作,推动红球菌领域的继续发展。     

An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile

Clostridium difficile infections (CDI) are caused by colonization and growth of toxigenic strains of C. difficile in individuals whose intestinal microbiota has been perturbed, in most cases following antimicrobial therapy. Determination of the protective commensal gut community members could inform the development of treatments for CDI. Here, we utilized the lethal enterocolitis model in Syrian golden hamsters to analyze the microbiota disruption and recovery along a 20-day period following a single dose of clindamycin on day 0, inducing in vivo susceptibility to C. difficile infection. To determine susceptibility in vitro, spores of strain VPI 10463 were cultured with and without soluble hamster fecal filtrates and growth was quantified by quantitative PCR and toxin immunoassay. Fecal microbial population changes over time were tracked by 16S ribosomal RNA gene analysis via V4 sequencing and the PhyloChip assay. C. difficile culture growth and toxin production were inhibited by the presence of fecal extracts from untreated hamsters but not extracts collected 5 days post-administration of clindamycin. In vitro inhibition was re-established by day 15, which correlated with resistance of animals to lethal challenge. A substantial fecal microbiota shift in hamsters treated with antibiotics was observed, marked by significant changes across multiple phyla including Bacteroidetes and Proteobacteria. An incomplete return towards the baseline microbiome occurred by day 15 correlating with the inhibition of C. difficile growth in vitro and in vivo. These data suggest that soluble factors produced by the gut microbiota may be responsible for the suppression of C. difficile growth and toxin production.     

Bile salt hydrolase-mediated inhibitory effect of <Emphasis Type="Italic">Bacteroides ovatus</Emphasis> on growth of <Emphasis Type="Italic">Clostridium difficile</Emphasis>

Clostridium difficile infection (CDI) is one of the most common nosocomial infections. Dysbiosis of the gut microbiota due to consumption of antibiotics is a major contributor to CDI. Recently, fecal microbiota transplantation (FMT) has been applied to treat CDI. However, FMT has important limitations including uncontrolled exposure to pathogens and standardization issues. Therefore, it is necessary to evaluate alternative treatment methods, such as bacteriotherapy, as well as the mechanism through which beneficial bacteria inhibit the growth of C. difficile. Here, we report bile acid-mediated inhibition of C. difficile by Bacteroides strains which can produce bile salt hydrolase (BSH). Bacteroides strains are not commonly used to treat CDI; however, as they comprise a large proportion of the intestinal microbiota, they can contribute to bile acid-mediated inhibition of C. difficile. The inhibitory effect on C. difficile growth increased with increasing bile acid concentration in the presence of Bacteroides ovatus SNUG 40239. Furthermore, this inhibitory effect on C. difficile growth was significantly attenuated when bile acid availability was reduced by cholestyramine, a bile acid sequestrant. The findings of this study are important due to the discovery of a new bacterial strain that in the presence of available bile acids inhibits growth of C. difficile. These results will facilitate development of novel bacteriotherapy strategies to control CDI.     

基于16S rRNA基因高通量测序研究狞猫肠道微生物多样性

[目的]研究狞猫肠道微生物多样性特征。[方法]对7只健康成年野生狞猫（2只雄性,5只雌性;2只来自济南野生动物园,5只来自威海野生动物园）粪便微生物16S rRNA基因V3-V4区进行高通量测序,对狞猫肠道微生物多样性进行研究。[结果] 7只狞猫共获得肠道微生物16S rRNA基因V3-V4区有效序列1458741条,平均208392条,序列平均长度433 bp。通过以97%的序列相似性进行分类,获得操作分类单元（OTU）平均 233个。经序列比对和分类鉴定,这些OTU都属于细菌域,包括13个门,26个纲,43个目,75个科,119个属。其中,丰度最高的细菌门是厚壁菌门（Firmicutes,平均占61.7%）、放线菌门（Actinobacteria,12.42%）、拟杆菌门（Bacteroidetes,7.79%）、梭杆菌门（Fusobacteroidetes,7.79%）和变形菌门（Proteobacteria,7.53%）。丰度最高的科依次是消化链球菌科（Peptostreptococcaceae,平均占16.15%）,梭菌科I（Clostridiaceae_I,14.78%）,毛螺菌科（Lachnospiraceae,13.13%）,红蝽杆菌科（Coriobacteriaceae,12.31%）等。丰度最高的属是柯林斯氏菌属（Collinsella,11.44%）,艰难梭菌属（Peptoclostridium,10.91%）,狭窄梭菌属1（Clostridium_sensu_stricto_1,10.3%）,拟杆菌属（Bacteroides,7.41%）,消化链球菌属（Peptostreptococcus,5.21%）等。7只狞猫的肠道微生物中有平均15.35%的OTU没有归类到属。样本间聚类分析结果表明,来自同一动物园的样本聚为一支。[结论]本文通过高通量测序技术研究了狞猫肠道微生物的组成和多样性特征,为狞猫的救护饲养和消化生理学研究提供基础数据。     

Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

Background

Clostridium difficile is an anaerobic, spore-forming bacterium that is the most common cause of healthcare-associated diarrhea in developed countries. A significant proportion of patients receiving oral vancomycin or metronidazole for treatment of Clostridium difficile infection (CDI) develop recurrences. However, the period of vulnerability to re-establishment of colonization by C. difficile after therapy is not well defined.

Principal Findings

In a prospective study of CDI patients, we demonstrated that most vancomycin-treated patients maintained inhibitory concentrations of vancomycin in stool for 4 to 5 days after therapy, whereas metronidazole was only detectable during therapy. From the time of elimination of the antibiotics to 14 to 21 days after therapy, a majority of stool suspensions supported growth of C. difficile and deep 16S rRNA sequencing demonstrated persistent marked alteration of the indigenous microbiota. By 21 to 28 days after completion of CDI treatment, a majority of stool suspensions inhibited growth of C. difficile and there was evidence of some recovery of the microbiota.

Conclusions

These data demonstrate that there is a vulnerable period for re-establishment of C. difficile colonization after CDI treatment that begins within a few days after discontinuation of treatment and extends for about 3 weeks in most patients.     

Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors

BackgroundThe impact of Clostridium difficile colonization in C. difficile infection (CDI) is inadequately explored. As a result, asymptomatic carriage is not considered in the development of infection control policies and the burden of carrier state in long-term care facilities (LTCFs) is unknown.PurposeTo explore the epidemiology of C. difficile colonization in LTCFs, identify predisposing factors and describe its impact on healthcare management.ResultsBased on data from 9 eligible studies that met the specified criteria and included 1,371 subjects, we found that 14.8% (95%CI 7.6%-24.0%) of LTCF residents are asymptomatic carriers of toxigenic C. difficile. Colonization estimates were significantly higher in facilities with prior CDI outbreak (30.1% vs. 6.5%, p = 0.01). Patient history of CDI (OR 6.07; 95% CI 2.06–17.88; effect derived from 3 studies), prior hospitalization (OR 2.11; 95% CI 1.08–4.13; derived from 3 studies) and antimicrobial use within previous 3 months (OR 3.68; 95% CI 2.04–6.62; derived from 4 studies) were associated with colonization. The predicted colonization rate at admission was 8.9%.ConclusionAsymptomatic carriage of toxigenic C. difficile represents a significant burden in LTCFs and is associated with prior CDI outbreaks in the facility, a history of CDI, prior hospitalization and antimicrobial use. These findings can impact infection control measures at LTCFs.     

基于CiteSpace的磷转化微生物研究文献计量和可视化分析

【背景】磷转化微生物对于自然环境中的磷循环具有重要作用。此类微生物通过对环境中磷素的溶解矿化和吸收转运等作用促进资源高效利用,减少环境污染,对粮食安全和生态系统稳定也具有积极的影响。【目的】探究近年来国内外关于磷转化微生物的发展热点及趋势,展示该领域的知识结构和知识演化过程,为后续研究提供可行性的参考和启示。【方法】应用Cite Space可视化软件对2002-2022年发表在中国知网(CNKI)和WebofScience(WOS)数据库中的文献通过关键词共现分析、关键词聚类分析、关键词突现分析、发文数量分析、国家分布、作者合作共现及机构合作共现等方式对磷转化微生物的研究现状及新兴趋势进行分析。【结果】最终共筛选出887篇有效文献。磷转化微生物研究在2016年后开始蓬勃发展,近几年增速加快;中国和美国学者是此领域重要的研究力量;中国是发文量最多的国家,中国科学院是发文量最多的机构;热门的研究领域为菌株的分类与筛选、代谢途径、营养元素循环以及环境污染与生态保护。【结论】磷转化微生物具有广阔的发展前景。目前,生物炭及磷转化微生物的响应机制正在成为新的研究热点。此类技术在未来的广泛应用是必然...